Felice Verduyn - Van Weegen
InvestorPartner at EQT Life Sciences
Amsterdam, Netherlands
Writes $11M – $65M checks · typically $25M
Contact· self-published, not guessed
Experience
- EQT GroupPartnercurrent2022 — presentAmsterdam, North Holland, Netherlands
- Agomab TherapeuticsMember Board of Directorscurrent2023 — presentGent, Vlaanderen, België
- EvommuneMember Board Of Directorscurrent2021 — presentVerenigde Staten
- Noema PharmaMember Board of Directorscurrent2024 — present
- Vico TherapeuticsMember of the Supervisory Boardcurrent2019 — presentLeiden, Provincie Zuid-Holland, Nederland
- Egle TherapeuticsMember Board Of Directorscurrent2021 — present
- LSPPartnercurrent2021 — present
- LSPInvestment Manager2015 — 2021Amsterdam Area
- EQT FoundationChairman of Grant Committeecurrent2025 — present
- De ZorgambassadeChairman of the supervisory board2019 — 2026
- Amolyt PharmaMember Board Of Directors2019 — 2024Lyon Area, France
- Pharvaris B.V.Board Observer2016 — 2021
- ONWARDBoard Observer2015 — 2018
- McKinsey & CompanyFellow2012 — 2014
- Harvard Medical SchoolGenetic research fellow2011Boston
- Vrije Universiteit AmsterdamGenetic and Twin Research2009 — 2011
- Dutch Twin Registry - Vrije UniversiteitGenetic and Twin Research2010
Skills & more
Dutch3Strategy8Management4Statistics7Research6Neuroscience3SPSS3Business Strategy9Management Consulting8Data Analysis2Due Diligence3Valuation4
+3 more
Mergers & AcquisitionsCorporate FinanceEntrepreneurshipFrom Felice's professional profile.
Deals · 1
EvommuneBoard seat
via EQT Life Sciences · filed Jan 2025 · $115.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at EQT Life Sciences
Alex Darden
Partner and Head of EQT Infrastructure Advisory Team Americas & President of EQT Partners Inc at EQT Ventures
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Chris Stone
Investor at EPIC VENTURES
Christina Drews
Chief Operating Officer at EQT Life Sciences
Network5
Amy Schulman
Managing Partner at Polaris Partners
Antoine Papiernik Papiernik
Chairman and Managing Partner at Sofinnova Partners
Ishaan Tewarie
Vice President at EQT Life Sciences
Nanna Luneborg
General Partner at Forbion
Rudy Dekeyser
Partner, Head of Health Economic Funds at EQT Life Sciences
Investors connected to Felice in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Felice Verduyn - Van Weegen?
- Partner at EQT Life Sciences
- Where does Felice Verduyn - Van Weegen work?
- Felice Verduyn - Van Weegen is Partner at EQT Life Sciences.
- What check size does Felice Verduyn - Van Weegen write?
- Felice Verduyn - Van Weegen typically writes checks of $11M – $65M.
- What boards does Felice Verduyn - Van Weegen sit on?
- Felice Verduyn - Van Weegen holds tracked board seats at Evommune.
- Where did Felice Verduyn - Van Weegen go to school?
- Felice Verduyn - Van Weegen studied at Columbia Business School (Master of Business Administration (MBA)); Vrije Universiteit Amsterdam (VU Amsterdam) (MsC, Neurosciences); Erasmus University Rotterdam (MsC, Neurosciences).
Same school
Also attended Columbia Business School883
Ryan PetersenFounder & CEO of FlexportAryo TehranianManaging Director at Mayfair Equity PartnersYibo NianInvestment Director at Intel CapitalKesha CashFounder & General Partner at Impact America FundMahati SridharPartner, Rise of the Rest at RevolutionGiuseppe IademarcoHead of Global Partnership at P101 Ventures
+ 877 more
Also attended Vrije Universiteit Amsterdam (VU Amsterdam)184
Brendan Bulik-SullivanInvestor at GV (Google Ventures)Johann FriederichAssociate at Notion CapitalTies KlinkhamerJunior Associate at Keen Venture PartnersAlex PortoInvestor at Riverwood CapitalMercedes TuinPartner at Heran PartnersProf. Dr. Jan Peter BalkenendeVoorzitter at Noaber
+ 178 more
Also attended Erasmus University Rotterdam244
Alessandro TavecchioPartner at P101 VenturesDick SietsesInvestment Partner Health at Capricorn Venture PartnersKonradInvestment Team at Hummingbird VenturesProf. Dr. Elbert DijkgraafBestuurslid at NoaberJohanneke van de Scheur-BaanBestuurslid at NoaberMaarten FischerHead of Programs at Noaber
+ 238 more
Shared employers
Also worked at Vico Therapeutics2
Also worked at LSP14
Drew BurdonInvestor at LSP (Life Sciences Partners)Anna BellmuntSenior Associate at Asabys PartnersRuben OsnabruggePartner & Chief Medical Officer at 415 CapitalJoachim RothePartner at EQT Life SciencesFouad AzzamPartner at EQT Life SciencesJohn de KoningPartner at EQT Life Sciences
+ 8 more
